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2012 probably represent only the so-
called tip of the iceberg. Nevertheless, 
PCR analysis to detect Schmallenberg 
virus in samples from animals with 
clinical signs is a valuable method for 
identifying first cases in areas where 
Schmallenberg virus infections have 
not previously been found. 
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Peritoneal  
Tuberculosis in a 
Pregnant Woman 
from Haiti,  
United States
To the Editor: A 29-year-old 
woman at 23 weeks’ gestation during 
her first pregnancy came to our hos-
pital’s obstetrics clinic after 6 days 
of vaginal bleeding and abdominal 
pain. She had not experienced fever, 
sweats, weight loss, contractions, or 
other symptoms. She was otherwise 
healthy; she was taking no medica-
tions, but was taking iron and multi-
vitamin supplements. She had legally 
immigrated to the United States from 
Haiti 8 months previously and had no 
known tuberculosis contacts. Physical 
examination disclosed brown vaginal 
discharge and a closed cervix. Obstet-
ric ultrasound was normal, and vagi-
nal swab samples were negative for 
Neisseria gonorrhea and Chlamydia 
trachomatis.
Over the ensuing 2 weeks, her 
vaginal bleeding and abdominal pain 
worsened. She was admitted to the 
hospital. Physical examination re-
vealed vaginal bleeding, but her con-
dition was otherwise unchanged. Rou-
tine laboratory studies were normal. 
Repeat obstetric ultrasound showed 
a viable fetus, ascites, and a 15 × 15 
× 3–cm rind of echogenic material an-
terior to the uterus. This abnormality 
was in the upper abdomen, an area not 
imaged on her previous ultrasound. 
Abdominal magnetic resonance imag-
ing revealed moderate ascites and a 21 
× 14 × 3–cm omental mass of interme-
diate intensity on T1 and T2 sequenc-
es; there was no lymphadenopathy 
(Figure). A tiny left pleural effusion 
was seen on chest radiograph. Routine 
HIV and tuberculin skin test results 
had been negative 4 months previ-
ously, and pre-immigration examina-
tion results and chest radiograph had 
been normal.
Fine-needle aspiration of the 
omental mass was nondiagnostic. The 
patient’s vaginal bleeding and abdom-
inal pain persisted, and her cervix di-
lated. She had an oral temperature of 
38.9° Celsius. Exploratory laparotomy 
demonstrated a friable omental mass 
with implants on the small bowel; a 
partial omentectomy was performed 
at 26 weeks’ gestation. During this 
procedure, the patient gave birth to a 
male infant.
Multiple granulomata, some 
containing acid-fast bacilli, were 
identified  upon  histologic  examina-
tion of the omentum (Technical Ap-
pendix Figure, wwwnc.cdc.gov/EID/
article/19/3/12-1109-Techapp1.pdf). 
Transcription-mediated  amplifica-
tion of the specimen was positive for 
Mycobacterium tuberculosis rRNA; 
cultures later grew M. tuberculosis 
susceptible to all first-line antitubercu-
losis medications. Sputum smears and 
cultures were not performed. The pa-
tient’s treatment began with isoniazid, 
rifampin, ethambutol, and pyrazin-
amide; her fevers and abdominal pain 
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resolved. Her son was admitted to the 
neonatal intensive care unit and was 
placed on antimycobacterial therapy. 
He also recovered and was discharged 
after 135 days.
This case highlights several is-
sues related to tuberculosis epidemi-
ology and diagnosis. Although pul-
monary disease is the most common 
manifestation of tuberculosis overall, 
extrapulmonary tuberculosis accounts 
for a significant and increasing propor-
tion of cases in the United States (1). 
Pregnancy is associated with greater 
likelihood of extrapulmonary disease; 
extrapulmonary infection accounts for 
13% of all cases worldwide (2) but 
50% of cases in pregnancy, according 
to a recent study (3).
The frequency of peritoneal tu-
berculosis in pregnancy is unknown; 
few cases have been reported in the 
literature (4–7), although we know of 
3 additional cases from Haiti (online 
Technical Appendix Table). However, 
cases are likely underdiagnosed or di-
agnosed late in the course of illness. 
Underdiagnosis and delayed diagno-
sis may be caused by the nonspecific 
nature of symptoms, commonly ab-
dominal pain and ascites, which can 
be attributed to pregnancy itself or 
obstetrical complications. These erro-
neous explanations for symptoms are 
reflected in this patient, whose symp-
toms were initially attributed to abrup-
tion and who was not diagnosed with 
tuberculosis until >3 weeks after seek-
ing medical assistance. Such delays 
in diagnosis are typical of peritoneal 
tuberculosis and are associated with 
increased death rates (8). In many cas-
es, clinical features cannot distinguish 
peritoneal tuberculosis from malig-
nancy, necessitating more extensive 
evaluation (7).
Failure to diagnose peritoneal tu-
berculosis, in pregnancy or otherwise, 
might also stem from the insensitiv-
ity of noninvasive diagnostic testing. 
Paracentesis with acid-fast staining 
detects only a minority of cases (8). 
The sensitivity of mycobacterial cul-
tures of ascites fluid varies, and cul-
ture results are often not available for 
weeks (8).  Ascites  fluid  adenosine 
deaminase has shown promise as a 
reliable, minimally invasive diagnos-
tic test in resource-poor countries, 
but was insensitive in a United States 
study (9). In addition, although tu-
berculin skin testing and interferon 
gamma release assay performance are 
not affected by pregnancy (10), nei-
ther can distinguish active from latent 
infection. Without diagnostic clinical 
features or sensitive noninvasive tests, 
the diagnosis of peritoneal tuberculo-
sis might only be confirmed through 
laparoscopy or laparotomy, as in our 
case. Such invasive testing methods 
and facilities, equipment, and person-
nel might not be readily available in 
resource-poor settings.
This case also illustrates the on-
going threat of tuberculosis in coun-
tries of all income levels. It is not 
clear where our patient contracted 
tuberculosis; she was most likely ex-
posed in Haiti, but transmission with-
in her Haitian community in the Unit-
ed States, or from another source, is 
also possible. Regardless, as in her 
case, a majority of tuberculosis cas-
es within the United States occur in 
foreign-born persons. Given the ease 
and frequency of travel, lapses in tu-
berculosis control in any locale are 
likely to have effects more broadly. 
Wherever they work, clinicians must 
maintain vigilance for tuberculosis in 
all of its protean forms.
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Microsporidial  
Keratoconjunctivitis 
Outbreak among 
Athletes from Hong 
Kong Who Visited 
Singapore, 2012
To the Editor: An international 
outbreak of microsporidial kerato-
conjunctivitis related to soil contact in a 
Singapore sport venue during April was 
reported to Hong Kong Department of 
Health, People’s Republic of China, in 
May 2012. Microsporidia are obligate 
intracellular, unicellular, eukaryotic, 
parasitic protists related to fungi (1). 
Fourteen species of microsporidia 
have been detected in humans (1). 
Several species of microsporidia, 
such as Vittaforma corneae, can cause 
keratoconjunctivitis (1). An increasing 
incidence of microsporidial keratitis in 
Singapore that is strongly correlated 
with exposure to soil was reported 
during 2004–2007 (2). In a case series 
of 22 patients during 2006–2008 in 
Singapore, soil or mud were reported 
as predominant ocular contaminants 
that were contacted by athletes during 
sporting activities, such as playing 
rugby in muddy fields (3).
The outbreak reported in May 
2012 affected 34 (41%) of 82 rugby 
players from Hong Kong who had 
participated in a rugby tournament in 
Singapore during April 21–22, 2012. 
In addition to the affected athletes from 
Hong Kong, there were 89, 15, 13, 
and 9 affected players, respectively, 
from Singapore, Malaysia, Australia, 
and United Arab Emirates (4). We 
conducted a retrospective cohort 
study among players from Hong 
Kong to identify potential risk and 
preventive factors for microsporidial 
keratoconjunctivitis.
The rugby tournament involved 
≈1,600 boys and girls from 16 rugby 
clubs in Singapore, Hong Kong, 
Malaysia, Australia, and the United 
Arab Emirates. We invited 82 boys 
(8–16 years of age) from 2 Hong Kong  
rugby clubs that participated in the 
tournament to participate in telephone 
interviews during May 18–25, 2012. 
Using a standardized questionnaire, 
we collected information describing 
demographics and potential risk and 
preventive  factors.  We  defined  a 
case-patient as any player who had 
eye redness and 1 of the following 
ocular signs or symptoms since April 
21: pain, discharge, swelling, or 
itchiness. 
We interviewed 73 (89%) of the 
82 players: 34 (47%) met the case 
definition.  The  median  age  of  case-
patients was 13 years (range 9–16 
years); these figures were not different 
from those of the cohort (median age 
13 years, range 8–16 years).
Onset of the reported 34 cases 
ranged from April 26 through May 
22, peaking on May 7 (Figure). The 
distribution of onset of cases over 
time indicates a point-source outbreak 
and reflects a wide range of incubation 
periods. Symptom onset occurred a 
median of 15 days (range 5–31 days) 
after opening day of the tournament.
Except for 2 players who had 
histories of asthma, all players reported 
good past health. Ocular signs and 
symptoms of the 34 case-patients were 
redness (100%), pain (53%), itchiness 
(53%), discharge (47%), and swelling 
(41%). Corneal scraping samples from 
3 players were positive for V. corneae 
by PCR.
Heavy  rainfall  on  playing  fields 
was reported on April 21, when all the 
players from Hong Kong participated 
in the games and were exposed to 
soil and muddy water. Some players 
washed their eyes after exposure to 
the  dirt  in  the  field.  We  identified 
the following as preventive factors 
for keratoconjunctivitis: individual 
eye washing by bottled or tap water 
(relative risk [RR] 0.38, 95% CI 
0.23–0.62), bottled water (RR 0.44, 
95% CI 0.25–0.76) and tap water (RR 
0.50, 95% CI 0.27–0.92). Group eye 
washing with water from a hose held 
by a trainer was not preventive. It is 
possible that individual eye washing 
by the players was more thorough.
The 47% attack rate among the 
players from Hong Kong is higher 
than the overall 10% (160/1,600) 
attack rate for tournament participants. 
Rugby players from Hong Kong 
might have been less aware of the 
risk of contracting microsporidial 
keratoconjunctivitis through soil or 
muddy water exposure than were 
players from other locations.
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